Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02599454
What this trial is testing

Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Stage I Non-Small Cell Lung Cancer
Megan Daly, MD 20
Early research (Phase 1)UnknownNCT03976856
What this trial is testing

Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Genor Biopharma Co., Ltd. 42
Large-scale testing (Phase 3)Study completedNCT00556322
What this trial is testing

Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 424
Not applicableUnknownNCT05815472
What this trial is testing

Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT)

Who this might be right for
Non-small-cell Lung Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT03620669
What this trial is testing

1st Line Durvalumab in PS 2 NSCLC Patients

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Swiss Cancer Institute 48
Not applicableUnknownNCT05837429
What this trial is testing

Low Volume High Intensity Interval Training in Operated Lung Cancer Patients

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Hacettepe University 40
Large-scale testing (Phase 3)UnknownNCT01066195
What this trial is testing

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 129
Testing effectiveness (Phase 2)Study completedNCT00723957
What this trial is testing

Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung Cancer
R-Pharm 260
Testing effectiveness (Phase 2)Looking for participantsNCT06092086
What this trial is testing

Lorlatinib as the First-line Treatment in China Advanced ALK+ NSCLC

Who this might be right for
ALK Positive Non-small Cell Lung Cancer
Guangdong Association of Clinical Trials 126
Testing effectiveness (Phase 2)UnknownNCT02688686
What this trial is testing

Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases

Who this might be right for
Non-Small-Cell Lung Cancer With Bone Metastases
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT01963351
What this trial is testing

Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC

Who this might be right for
Non-small Cell Lung CancerUnresectable Malignant Neoplasm
University of Athens 150
Not applicableStudy completedNCT00310219
What this trial is testing

Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 52
Testing effectiveness (Phase 2)UnknownNCT03399669
What this trial is testing

The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04743505
What this trial is testing

Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Washington University School of Medicine 27
Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Testing effectiveness (Phase 2)UnknownNCT04619537
What this trial is testing

A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Testing effectiveness (Phase 2)Study completedNCT06029127
What this trial is testing

Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 35
Not applicableStudy completedNCT02562027
What this trial is testing

SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell-LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Washington University School of Medicine 217
Large-scale testing (Phase 3)Study completedNCT01999673
What this trial is testing

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer Stage IIIBNon-Small-Cell Lung Cancer Stage IVNon-Small-Cell Lung Cancer Metastatic+4 more
Peregrine Pharmaceuticals 582
Next Page